您的位置: 首页 > 农业专利 > 详情页

Sustained release delivery of active agents to treat glaucoma and ocular hypertension
专利权人:
Zuhal Butuner
发明人:
Zuhal Butuner
申请号:
US12463279
公开号:
US09949942B2
申请日:
2009.05.08
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The methods described herein provide treatment of glaucoma, ocular hypertension, and elevated intraocular pressure with latanoprost or other therapeutic agent(s). Implant devices for insertion into a punctum of a patient provide sustained release of latanoprost or other therapeutic agent(s) that is maintained for 7, 14, 21, 30, 45, 60, or 90 days or more, thus avoiding patient noncompliance and reducing or lowering adverse events associated with eye drop administration of latanoprost or other therapeutic agent(s) and other therapeutic agent(s).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充